Alaunos Therapeutics Inc.

TCRT | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.26

+$0.06 (+5.00%)

At close: Sep 21, 2026, 4:00 PM ET

$1.26

$0 (0.00%)

After-hours: Sep 21, 2026, 7:38 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+5.00%

(1D)

Rating

Updated: Aug 18, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.08M

1D Range

1.22 1.35

52W Range

1.02 4.59

Valuation (TTM)

PE -0.65

PB 4.72

EV/EBITDA -0.74

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target N/A

Cash Flow

FCF Yield -91.8%

SBC Adj. FCF Yield -100.7%

SBC Impact -9.7%

Margins

Gross Margin -28133.3%

Operating Margin -135266.7%

FCF Margin -94166.6%

Growth (CAGR)

Revenue 3Y | 5Y -89.9% | -55.6%

Dil EPS 3Y | 5Y 91.7% | 59.8%

FCF 3Y | 5Y 94.7% | 55.3%

Returns

ROA -264.5%

ROE -232.6%

ROIC -622.4%

Financial Health

Net Cash

$124K

Current Ratio 0.77

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Librar...

Sector Healthcare

Industry Biotechnology

Employees 1

IPO Date Aug 23, 2005

Website www.alaunos.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.